Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies ; volume:35 ; number:7 ; day:7 ; month:7 ; year:2021 ; pages:781-794 ; date:7.2021
CNS drugs ; 35, Heft 7 (7.7.2021), 781-794, 7.2021
- Creator
-
Doty, Richard L.
Popova, Vanina
Wylie, Crystal
Fedgchin, Maggie
Daly, Ella
Janik, Adam
Ochs-Ross, Rachel
Lane, Rosanne
Lim, Pilar
Cooper, Kim
Melkote, Rama
Jamieson, Carol
Singh, Jaskaran
Drevets, Wayne C.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-021-00826-9
- URN
-
urn:nbn:de:101:1-2021102402545503841325
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Doty, Richard L.
- Popova, Vanina
- Wylie, Crystal
- Fedgchin, Maggie
- Daly, Ella
- Janik, Adam
- Ochs-Ross, Rachel
- Lane, Rosanne
- Lim, Pilar
- Cooper, Kim
- Melkote, Rama
- Jamieson, Carol
- Singh, Jaskaran
- Drevets, Wayne C.
- SpringerLink (Online service)
Other Objects (12)
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials
Effects of nasal inflammation on the olfactory bulb
The nasal microbiome mirrors and potentially shapes olfactory function
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant
Personalized use of ketamine and esketamine for treatment-resistant depression
Correlations between gustatory, trigeminal, and olfactory functions and nasal airflow
Correlations between gustatory, trigeminal, and olfactory functions and nasal airflow
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
Nasal physiology and pathophysiology of nasal disorders
III. Nasale.
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials
Effects of nasal inflammation on the olfactory bulb
The nasal microbiome mirrors and potentially shapes olfactory function
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant
Personalized use of ketamine and esketamine for treatment-resistant depression
Correlations between gustatory, trigeminal, and olfactory functions and nasal airflow
Correlations between gustatory, trigeminal, and olfactory functions and nasal airflow
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
Nasal physiology and pathophysiology of nasal disorders
III. Nasale.
Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program
Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials
Effects of nasal inflammation on the olfactory bulb
The nasal microbiome mirrors and potentially shapes olfactory function
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant
Personalized use of ketamine and esketamine for treatment-resistant depression
Correlations between gustatory, trigeminal, and olfactory functions and nasal airflow
Correlations between gustatory, trigeminal, and olfactory functions and nasal airflow
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
Nasal physiology and pathophysiology of nasal disorders